# Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis

> **NCT04166396** · EARLY_PHASE1 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 8 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Resveratrol
- **DRUG:** NR
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04166396
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-17
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04166396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04166396, "Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04166396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*